Article
Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.
Human molecular genetics - 1 May 2012
Purevjav Enkhsaikhan, Arimura Takuro, Augustin Sibylle, Huby Anne-Cecile, Takagi Ken, Nunoda Shinichi, Kearney Debra L, Taylor Michael D, Terasaki Fumio, Bos Johan M, Ommen Steve R, Shibata Hiroki, Takahashi Megumi, Itoh-Satoh Manatsu, McKenna William J, Murphy Ross T, Labeit Siegfried, Yamanaka Yoichi, Machida Noboru, Park Jeong-Euy, Alexander Peta M A, Weintraub Robert G, Kitaura Yasushi, Ackerman Michael J, Kimura Akinori, Towbin Jeffrey A
Abstract excerpt
Abnormalities in Z-disc proteins cause hypertrophic (HCM), dilated (DCM) and/or restrictive cardiomyopathy (RCM), but disease-causing mechanisms are not fully understood. Myopalladin (MYPN) is a Z-disc protein expressed in striated muscle and functions as a structural, signaling and gene expression regulating molecule in response to muscle stress. MYPN was genetically screened in 900 patients with HCM, DCM and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
